Latest Breaking News On - Novel hybrid gene therapy approach - Page 1 : comparemela.com

/PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with.

United statesLos angelesAmerican society of genePrnewswire poseida therapeutics incTechnology reactivates fetal hemoglobinPoseida therapeutics incTechnology enables precise gene editingLos angeles convention centerAmerican societyCell therapyAnnual meetingPreclinical proof of conceptNovel hybrid gene therapy approachGastrointestinal diseasesEnables precise gene editingSite specific transgene insertion